212 related articles for article (PubMed ID: 8323356)
1. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
[TBL] [Abstract][Full Text] [Related]
2. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
Merz U; Pfäffle R; Peschgens T; Hörnchen H
Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
[TBL] [Abstract][Full Text] [Related]
3. Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone.
Cronin CM; Dean H; MacDonald NT; Seshia MM
Clin Invest Med; 1993 Feb; 16(1):8-14. PubMed ID: 8385590
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
Kazzi NJ; Brans YW; Poland RL
Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.
Harkavy KL; Scanlon JW; Chowdhry PK; Grylack LJ
J Pediatr; 1989 Dec; 115(6):979-83. PubMed ID: 2685220
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants.
Wilson DM; Baldwin RB; Ariagno RL
J Pediatr; 1988 Oct; 113(4):764-8. PubMed ID: 3050006
[TBL] [Abstract][Full Text] [Related]
11. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up.
Mammel MC; Fiterman C; Coleman M; Boros SJ
Dev Pharmacol Ther; 1987; 10(1):1-11. PubMed ID: 3582071
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum leptin concentration after corticosteroid treatment in preterm infants.
Ng PC; Lam CW; Lee CH; Fok TF; Chan IH; Ma KC; Wong E
Acta Paediatr; 2002; 91(6):684-90. PubMed ID: 12162603
[TBL] [Abstract][Full Text] [Related]
13. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
Cummings JJ; D'Eugenio DB; Gross SJ
N Engl J Med; 1989 Jun; 320(23):1505-10. PubMed ID: 2657423
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH
Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095
[TBL] [Abstract][Full Text] [Related]
18. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia--a pilot study.
Tonini G; Pahor T; Colonna F; de Vonderweid U
J Pediatr Endocrinol Metab; 1997; 10(3):291-4. PubMed ID: 9388821
[TBL] [Abstract][Full Text] [Related]
20. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
Ng PC; Lam CW; Lee CH; Chan IH; Wong SP; Fok TF
Neonatology; 2008; 94(3):170-5. PubMed ID: 18612214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
